European Study to Evaluate Preliminary Safety and Efficacy of Multiple Obalon Gastric Balloons for 12 Weeks as an Aid for Weight Loss

NCT01718886 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2012-10-31

No results posted yet for this study

Summary

The objective of this study is to evaluate the initial safety and preliminary effectiveness of the Obalon intragastric balloon system in European subjects with a BMI in the range of 27 - 35 kg/m\^2

Conditions

Interventions

DEVICE

Obalon Gastric Balloon

Sponsors & Collaborators

  • Obalon Therapeutics, Inc.

    lead INDUSTRY

Principal Investigators

  • Fancois Mion, MD · Hospital Edouard Harriot

  • Jacques Deviere · Erasme hospital

Eligibility

Min Age
21 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • Belgium
  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01718886 on ClinicalTrials.gov